Active Pharmaceutical Ingredient (API) is the part of any drug product. Pharmaceutical drugs might be available in type of capsules or tablets yet their genuine components are a long way from homogenous. Active Pharmaceutical Ingredient (API) is known as that part of the chemical included in the drugs which treats the cause and that actually works on the condition. Contents in drugs is not static it may contain one or more API and according to the dosage or prescription it will differ from person to person. Pharmaceutical technologists are prevalently possessed with the creation of different dose structures, for example, tablets, pastilles or dragees. The enhancing access to healthcare with the fast penetration of technology and different advancements in the healthcare segment.
How Big is the Global Active Pharmaceutical Ingredient (API) Market?
The Global Active Pharmaceutical Ingredient (API) Market is expected to be around US$ 275 Billion by 2028 at a CAGR of 6% in the given forecast period.
The major driving factors of Global Active Pharmaceutical Ingredient (API) Market are as follows:
The restraining factors of Global Active Pharmaceutical Ingredient (API) Market are as follows:
The Global Active Pharmaceutical Ingredient (API) Market is segmented on the lines of its manufacturing process, API type, therapeutic area, drug type and regional. Based on manufacturing process segmentation it covers captive, contract. Based on API type segmentation it covers synthetic chemical API, biological API. Based on therapeutic area segmentation it covers cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, other therapeutics uses. Based on drug type segmentation it covers branded prescription drugs, generic prescription drugs, OTC prescription drugs. The Global Active Pharmaceutical Ingredient (API) Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Active Pharmaceutical Ingredient (API) Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023 and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Active Pharmaceutical Ingredient (API) Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets onGlobal Active Pharmaceutical Ingredient (API) Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Allergan plc, BASF SE, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd., Lonza Group, Mylan, Inc., Sandoz (Novartis AG), Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and WuXiApptec. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Active Pharmaceutical Ingredient (API) Market has been segmented as below:
By Manufacturing Process Analysis:
By API Type Analysis:
By Therapeutic Area Analysis:
By Drug Type Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Active Pharmaceutical Ingredient (API) Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Active Pharmaceutical Ingredient (API) Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Key Industry Insights
2.6 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Active Pharmaceutical Ingredients Market Overview
4.2 Active Pharmaceutical Ingredients Market, By Type of Manufacturer
4.3 Active Pharmaceutical Ingredients Market, By Therapeutic Area
4.4 Biotech Active Pharmaceutical Ingredients Market, By Product
4.5 Active Pharmaceutical Ingredients Market, By Type of Drug
4.6 Active Pharmaceutical Ingredients Market: Geographic Snapshot
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Chronic Diseases
5.2.1.2 Rising Prevalence of Cancer
5.2.1.3 Technological Advancements in API Manufacturing
5.2.1.4 Growing Importance of Generics
5.2.1.5 Rapidly Increasing Geriatric Population
5.2.1.6 Increase in Abbreviated New Drug Applications (ANDA)
5.2.1.7 Increasing Uptake of Biopharmaceuticals
5.2.2 Restraints
5.2.2.1 Stringent Regulatory Requirements
5.2.2.2 Unfavorable Drug Price Control Policies Across Various Countries
5.2.3 Opportunities
5.2.3.1 Emerging Biosimilars Market
5.2.3.2 Increasing Scope for High-Potency Active Pharmaceutical Ingredients
5.2.3.3 Emerging Markets
5.2.3.4 Emerging Technologies
5.2.4 Challenges
5.2.4.1 Product Differentiation
5.2.4.2 High Manufacturing Costs
6 Active Pharmaceutical Ingredients Market, By Type
6.1 Introduction
6.2 Innovative Active Pharmaceutical Ingredients
6.3 Generic Active Pharmaceutical Ingredients
7 Active Pharmaceutical Ingredients Market, By Type of Manufacturer
7.1 Introduction
7.2 Captive Manufacturers
7.3 Merchant API Manufacturers
7.3.1 Merchant Manufacturers Market, By Type
7.3.1.1 Innovative Merchant API Manufacturers
7.3.1.2 Generic Merchant API Manufacturers
7.3.2 Merchant API Manufacturers Market, By Mode of Synthesis
7.3.2.1 Synthetic APIs
7.3.2.2 Biotech APIs
8 Active Pharmaceutical Ingredients Market, By Type of Synthesis
8.1 Introduction
8.2 Synthetic Active Pharmaceutical Ingredients
8.2.1 Synthetic Active Pharmaceutical Ingredients Market, By Type
8.2.1.1 Innovative Synthetic APIs
8.2.1.2 Generic Synthetic APIs
8.3 Biotech Active Pharmaceutical Ingredients
8.3.1 Biotech Active Pharmaceutical Ingredients Market, By Type
8.3.1.1 Innovative Biotech APIs
8.3.1.2 Biosimilars
8.3.2 Biotech Active Pharmaceutical Ingredients Market, By Product
8.3.2.1 Monoclonal Antibodies
8.3.2.2 Vaccines
8.3.2.3 Hormones and Growth Factors
8.3.2.4 Cytokines
8.3.2.5 Fusion Proteins
8.3.2.6 Therapeutic Enzymes
8.3.2.7 Blood Factors
8.3.3 Biotech Active Pharmaceutical Ingredients Market, By Expression System
8.3.3.1 Mammalian Expression Systems
8.3.3.2 Microbial Expression Systems
8.3.3.3 Yeast Expression Systems
8.3.3.4 Plant Expression Systems
8.3.3.5 Insect Expression Systems
9 Active Pharmaceutical Ingredients Market, By Type of Drug
9.1 Introduction
9.2 Prescription Drugs
9.3 Over-The-Counter Drugs
9.4 Active Pharmaceutical Ingredients Market, By Potency
9.4.1 Low to Moderate Potency Active Pharmaceutical Ingredients
9.4.2 Potent to Highly Potent Active Pharmaceutical Ingredients
10 Active Pharmaceutical Ingredients Market, By Therapeutic Application
10.1 Introduction
10.2 Oncology
10.3 Cardiovascular Disease
10.4 Diabetes
10.5 Central Nervous System and Neurological Disorders
10.6 Endocrinology
10.7 Other Therapeutic Applications
11 Active Pharmaceutical Ingredients Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe (RoE)
11.4 Asia
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of Asia (RoA)
11.5 Rest of the World (RoW)
12 Competitive Landscape
12.1 Overview
12.2 Market Player Ranking
12.3 Competitive Situation and Trends
12.3.1 Agreements, Collaborations, Partnerships, Joint Ventures, and Alliances
12.3.2 Regulatory Approvals
12.3.3 Mergers and Acquisitions
12.3.4 Expansions
12.3.5 Investments
13 Company Profiles
13.1 Introduction
13.2 Pfizer, Inc.
13.3 Novartis International AG
13.4 Sanofi
13.5 Boehringer Ingelheim
13.6 Bristol-Myers Squibb
13.7 Teva Pharmaceutical Industries Ltd.
13.8 ELI Lilly and Company
13.9 Glaxosmithkline PLC
13.10 Merck & Co., Inc.
13.11 Abbvie Inc.
The Global Active Pharmaceutical Ingredient (API) Market has been segmented as below:
By Manufacturing Process Analysis:
By API Type Analysis:
By Therapeutic Area Analysis:
By Drug Type Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
